Development and Validation of a Novel Model for Predicting Prognosis of Non-PCR Patients After Neoadjuvant Therapy for Breast Cancer

PURPOSE: Pathologic complete response (pCR) after neoadjuvant therapy is an important indicator of long-term prognosis and the primary endpoint of many neoadjuvant studies. For breast cancer patients who do not achieve pCR, prognostic indicators related to prognosis are particularly important. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yongqiang, Wu, Si, Xing, Hui, Han, Mengxue, Li, Jinze, Liu, Yueping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440922/
https://www.ncbi.nlm.nih.gov/pubmed/34540660
http://dx.doi.org/10.3389/fonc.2021.675533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440922/
https://www.ncbi.nlm.nih.gov/pubmed/34540660
http://dx.doi.org/10.3389/fonc.2021.675533

Ejemplares similares